Clinical Trials › NCT05092191
RecruitingPhase 2
Cannabis as a Complementary Treatment in Multiple Sclerosis
Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 250
Target enrollment
Nov 2022
Start date
May 2025
Expected completion
Interventions / Treatments
Cannabis oil vs placebo
Conditions studied
Multiple Sclerosis
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
More Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.